United States · FDA National Drug Code directory

EPIPEN JR

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
49502-501_81569d26-e9b3-4c1d-ac34-8a4cf5b4a98b
Product NDC
49502-501
Form
INJECTION
Composition / generic term
epinephrine
Labeler
Viatris Specialty LLC
Marketing category
NDA
Marketing start / end (source format)
19871222
Source listing expiry
20261231

Source-listed ingredients

  • EPINEPHRINE — .15 mg/.3mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 2 CONTAINER in 1 CARTON (49502-501-02) / 1 SYRINGE, GLASS in 1 CONTAINER (49502-501-01) / .3 mL in 1 SYRINGE, GLASS · 49502-501-02
  • 2 CONTAINER in 1 CARTON (49502-501-92) / 1 SYRINGE, GLASS in 1 CONTAINER / .3 mL in 1 SYRINGE, GLASS · 49502-501-92

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →